Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia

Psychiatric Genetics

Volumn 20, Issue 6, 2010, Pages 289-297

  Ancín, Inés ^a   Barabash, Ana ^a   Vázquez Álvarez, Blanca ^a   Santos, José Luis ^b   Sánchez Morla, Eva ^b   Martínez, José Luis ^a   Aparicio, Ana ^b   Peláez, José Carlos ^a   Cabranes Díaz, José Antonio ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Virgen de la Luz Hospital   (Spain)

Author keywords

bipolar disorder; CHRNA7; genetics; psychosis; schizophrenia

Indexed keywords

NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA7; NICOTINIC RECEPTOR; NUCLEOTIDE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; ARTICLE; BIPOLAR DISORDER; CHRNA7 GENE; CHROMOSOME 15Q; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; BIPOLAR DISORDER; FEMALE; GENE DUPLICATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NICOTINIC; SCHIZOPHRENIA;

ANIMALIA;

EID: 78049525438     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32833a9b7a     Document Type: Article

References (102)

1. Albuquerque EX, Alkondon M, Pereira EF, Castro NG, Schrattenholz A, Barbosa CT, et al. (1997). Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280:1117-1136
2. American Psychiatric Association (A.P.A.) (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, Tet revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
3. Beasley CL, Zhang ZJ, Patten I, Reynolds GP (2002). Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 52:708-715.
4. Benes FM, Berretta S (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmaco-logy 25:1-27.
5. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS (1998). A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44:88-97.
6. Benes FM, Vincent SL, Todtenkopf M (2001). The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 50:395-406.
7. 125I]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol 387:385-398.
8. Carson R, Craig D, Hart D, Todd S, McGuinness B, Johnston JA, et al. (2008). Genetic variation in the alpha7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease. Neuromolecular Med 10:377-384.
9. Chen XS, Zhang MD, Wang HX, Lou CY, Wang JJ, Guo Q, et al. (2005). Sensory gating of patients with first-episode schizophrenia. Zhonghua Yi Xue Za Zhi 85:3457-3459.
10. Chini B, Raimond E, Elgoyhen AB, Moralli D, Balzaretti M, Heinemann S (1994). Molecular cloning and chromosomal localization of the human alpha 7-nicotinic receptor subunit gene (CHRNA7). Genomics 19: 379-381.
11. Chomczynski P, Mackey K, Drews R, Wilfinger W (1997). DNAzol: a reagent for the rapid isolation of genomic DNA. Biotechniques 22:550-553.
12. Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, et al. (1999). Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J Neuro-chem 73:1590-1597.
13. Craddock N, Lendon C (1999). Chromosome workshop: chromosomes 11, 14, and 15. Am J Med Genet 88:244-254.
14. Curtis L, Blouin JL, Radhakrishna U, Gehrig C, Lasseter VK, Wolyniec P, et al. (1999). No evidence for linkage between schizophrenia and markers at chromosome 15q13-14. Am J Med Genet 88:109-112.
15. Dajas-Bailador F, Wonnacott S (2004). Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25:317-324.
16. De Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L (2002). Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res 56:47-54.
17. De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH (2006). Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia. Acta Psychiatr Scand 114:211-215.
18. Edenberg HJ, Foroud T, Conneally PM, Sorbel JJ, Carr K, Crose C, et al. (1997). Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. Am J Med Genet 74:238-246. (Pubitemid 27251221)
19. Fan JB, Ma J, Li XW, Zhang CS, Sun WW, He G, et al. (2006). Population-based and family-based association studies of an (AC)n dinucleotide repeat in alpha-7 nicotinic receptor subunit gene and schizophrenia. Schizophr Res 84:222-227.
20. Faraone SV, Glatt SJ, Su J, Tsuang MT (2004a). Three potential susceptibility loci shown by a genome-wide scan for regions influencing the age at onset of mania. Am J Psychiatry 161:625-630.
21. Faraone SV, Su J, Taylor L, Wilcox M, Van EP, Tsuang MT (2004b). A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for smoking in schizophrenia families. Hum Hered 57:59-68.
22. Flomen RH, Collier DA, Osborne S, Munro J, Breen G, St CD, et al. (2006). Association study of CHRFAM7A copy number and 2 bp deletion polymorphisms with schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 141:571-575.
23. Flomen RH, Davies AF, Di FM, Cascia CL, Kie-Ogilvie C, Murray R, et al. (2008). The copy number variant involving part of the alpha7 nicotinic receptor gene contains a polymorphic inversion. Eur J Hum Genet 16:1364-1371.
24. Freedman R, Leonard S (2001). Genetic linkage to schizophrenia at chromosome 15q14. Am J Med Genet 105:655-657.
25. Freedman R, Hall M, Adler LE, Leonard S (1995). Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:22-33.
26. Freedman R, Adler LE, Myles-Worsley M, Nagamoto HT, Miller C, Kisley M, et al. (1996). Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. Arch Gen Psychiatry 53:1114-1121.
27. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, et al. (1997). Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:587-592.
28. Freedman R, Adams CE, Leonard S (2000). The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J Chem Neuroanat 20:299-306.
29. Freedman R, Leonard S, Gault JM, Hopkins J, Cloninger CR, Kaufmann CA, et al. (2001). Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). Am J Med Genet 105:20-22.
30. Freedman R, Leonard S, Waldo M, Gault J, Olincy A, Adler LE (2006). Characterization of allelic variants at chromosome 15q14 in schizophrenia. Genes Brain Behav 5 (Suppl 1):14-22.
31. Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, et al. (2008). Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry 165:1040-1047.
32. 2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 35:1-8.
33. Garcia-Guzman M, Sala F, Sala S, Campos-Caro A, Stuhmer W, Gutierrez LM, et al. (1995). alpha-Bungarotoxin-sensitive nicotinic receptors on bovine chromaffin cells: molecular cloning, functional expression and alternative splicing of the alpha 7 subunit. Eur J Neurosci 7:647-655.
34. Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J, et al. (1998). Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 52:173-185.
35. Gault J, Hopkins J, Berger R, Drebing C, Logel J, Walton C, et al. (2003). Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. Am J Med Genet B Neuropsychiatr Genet 123:39-49.
36. Gejman PV, Sanders AR, Badner JA, Cao Q, Zhang J (2001). Linkage analysis of schizophrenia to chromosome 15. Am J Med Genet 105:789-793.
37. George TP, O'Malley SS (2004). Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci 25:42-48.
38. Gotti C, Fornasari D, Clementi F (1997). Human neuronal nicotinic receptors. Prog Neurobiol 53:199-237.
39. Guan ZZ, Zhang X, Blennow K, Nordberg A (1999). Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport 10:1779-1782.
40. Hall MH, Rijsdijk F, Kalidindi S, Schulze K, Kravariti E, Kane F, et al. (2007). Genetic overlap between bipolar illness and event-related potentials. Psychol Med 37:667-678. (Pubitemid 46519750)
41. Hall MH, Schulze K, Sham P, Kalidindi S, McDonald C, Bramon E, et al. (2008). Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: a combined twin and family study. Am J Med Genet B Neuropsychiatr Genet 147B:619-627.
42. Hashimoto K, Iyo M, Freedman R, Stevens KE (2005). Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors. Psychopharmacology (Berl) 183:13-19.
43. Hong CJ, Lai IC, Liou LL, Tsai SJ (2004). Association study of the human partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant with bipolar disorder. Neurosci Lett 355:69-72.
44. Houy E, Raux G, Thibaut F, Belmont A, Demily C, Allio G, et al. (2004). The promoter-194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit. Mol Psychiatry 9:320-322.
45. International Schizophrenia Consortium (2008). Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455:237-241.
46. Iwata Y, Nakajima M, Yamada K, Nakamura K, Sekine Y, Tsuchiya KJ, et al. (2007). Linkage disequilibrium analysis of the CHRNA7 gene and its partially duplicated region in schizophrenia. Neurosci Res 57:194-202.
47. Judd LL, McAdams L, Budnick B, Braff DL (1992). Sensory gating deficits in schizophrenia: new results. Am J Psychiatry 149:488-493.
48. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD, et al. (1998). NIMH genetics initiative millenium schizophrenia consortium: linkage analysis of African-American pedigrees. Am J Med Genet 81:282-289.
49. Kumari V, Postma P (2005). Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29:1021-1034.
50. Lai IC, Hong CJ, Tsai SJ (2001). Association study of a nicotinic receptor variant with schizophrenic disorders. Neuropsychobiology 43:15-18.
51. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH (2000). Smoking and mental illness: a population-based prevalence study. JAMA 284:2606-2610.
52. Leonard S, Freedman R (2006). Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry 60:115-122.
53. Leonard S, Gault J, Adams C, Breese CR, Rollins Y, Adler LE, et al. (1998a). Nicotinic receptors, smoking and schizophrenia. Restor Neurol Neurosci 12:195-201.
54. Leonard S, Gault J, Moore T, Hopkins J, Robinson M, Olincy A, et al. (1998b). Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH genetics initiative. Am J Med Genet 81:308-312.
55. Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C, et al. (2001). Smoking and mental illness. Pharmacol Biochem Behav 70:561-570.
56. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, et al. (2002). Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 59:1085-1096.
57. Levin ED (2002). Nicotinic receptor subtypes and cognitive function. J Neurobiol 53:633-640.
58. Levin ED, Simon BB (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138:217-230.
59. Li CH, Liao HM, Chen CH (2004). Identification of molecular variants at the promoter region of the human alpha 7 neuronal nicotinic acetylcholine receptor subunit gene but lack of association with schizophrenia. Neurosci Lett 372:1-5.
60. Liu CM, Hwu HG, Lin MW, Ou-Yang WC, Lee SF, Fann CS, et al. (2001). Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. Am J Med Genet 105:658-661.
61. Louchart-de la CS, Levillain D, Menard JF, Van der EA, Allio G, Haouzir S, et al. (2005). P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia. Psychiatry Res 136:27-34.
62. Ma J, Fan JB, Bian L, Zhang CS, Li XW, Gu NF, et al. (2008). Association study of a (TG)n dinucleotide repeat at chromosome 15q13.3 and schizophrenia in the Chinese population. Psychiatry Res 159:245-249.
63. Mackey K, Williams P, Seim S, Chomczynski P (1996). The use of DNAzol for the rapid isolation of genomic DNA from whole blood. Biomed Products Supplement 3:13-15.
64. Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS, et al. (2003). The underlying neurobiology of bipolar disorder. World Psychiatry 2:136-146.
65. Martin LF, Kem WR, Freedman R (2004). Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharma-cology (Berl) 174:54-64.
66. Martin LF, Leonard S, Hall MH, Tregellas JR, Freedman R, Olincy A (2007). Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. Am J Med Genet B Neuropsychiatr Genet 144:611-614.
67. McGehee DS, Role LW (1995). Physiological diversity of nicotinic acetylcho-line receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521-546.
68. Neves-Pereira M, Bassett AS, Honer WG, Lang D, King NA, Kennedy JL (1998). No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families. Am J Med Genet 81:361-363.
69. Newhouse PA, Potter A, Singh A (2004). Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol 4:36-46.
70. O'Neill HC, Rieger K, Kem WR, Stevens KE (2003). DMXB, an alpha7 nicotinic agonist, normalizes auditory gating in isolation-reared rats. Psychopharma-cology (Berl) 169:332-339.
71. Olincy A, Martin L (2005). Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry 162:43-49.
72. Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, et al. (2006). Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63:630-638.
73. Peng Z, Wan X, Jiang T, Cheng L, Sun B, Hong X (2008). The transmission disequilibrium analysis between neuronal nicotinic acetylcholine receptor alpha 7 subunit gene polymorphisms and schizophrenia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25:154-158.
74. Perl O, Ilani T, Strous RD, Lapidus R, Fuchs S (2003). The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes. FASEB J 17:1948-1950.
75. Perl O, Strous RD, Dranikov A, Chen R, Fuchs S (2006). Low levels of alpha7-nicotinic acetylcholine receptor mRNA on peripheral blood lymphocytes in schizophrenia and its association with illness severity. Neuropsychobiology 53:88-93.
76. Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004). Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4:850-860.
77. Picciotto MR, Caldarone BJ, King SL, Zachariou V (2000). Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharma-cology 22:451-465.
78. Raux G, Bonnet-Brilhault F, Louchart S, Houy E, Gantier R, Levillain D, et al. (2002). The-2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit. Mol Psychiatry 7:1006-1011.
79. Reif A, Kress W, Wurm K, Benninghoff J, Pfuhlmann B, Lesch KP (2004). Duplication 15q14-pter: a rare chromosomal abnormality underlying bipolar affective disorder. Eur Psychiatry 19:179-181.
80. Riley B, Williamson M, Collier D, Wilkie H, Makoff A (2002). A 3-Mb map of a large Segmental duplication overlapping the alpha7-nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13-q14. Genomics 79:197-209.
81. Riley BP, Makoff A, Mogudi-Carter M, Jenkins T, Williamson R, Collier D, et al. (2000). Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. Am J Med Genet 96:196-201.
82. Ripoll N, Bronnec M, Bourin M (2004). Nicotinic receptors and schizophrenia. Curr Med Res Opin 20:1057-1074.
83. Role LW, Berg DK (1996). Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16:1077-1085.
84. Sanchez-Morla EM, Garcia-Jimenez MA, Barabash A, Martinez-Vizcaino V, Mena J, Cabranes-Diaz JA, et al. (2008). P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr Scand 117:313-318.
85. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, et al. (2008). No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 165:497-506.
86. Seguela P, Wadiche J, Neley-Miller K, Dani JA, Patrick JW (1993). Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604.
87. Severance EG, Yolken RH (2008). Novel alpha7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia. Genes Brain Behav 7:37-45.
88. Severance EG, Zhang H, Cruz Y, Pakhlevaniants S, Hadley SH, Amin J, et al. (2004). The alpha7 nicotinic acetylcholine receptor subunit exists in two isoforms that contribute to functional ligand-gated ion channels. Mol Pharmacol 66:420-429.
89. Shi J, Hattori E, Zou H, Badner JA, Christian SL, Gershon ES, et al. (2007). No evidence for association between 19 cholinergic genes and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 144:715-723. (Pubitemid 47417198)
90. Simosky JK, Stevens KE, Kem WR, Freedman R (2001). Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice. Biol Psychiatry 50:493-500.
91. Sinkus ML, Lee MJ, Gault J, Logel J, Short M, Freedman R, et al. (2009). A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res 1291:1-11.
92. Stassen HH, Bridler R, Hagele S, Hergersberg M, Mehmann B, Schinzel A, et al. (2000). Schizophrenia and smoking: evidence for a common neurobiological basis? Am J Med Genet 96:173-177.
93. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, et al. (2008). Large recurrent microdeletions associated with schizophrenia. Nature 455:232-236.
94. Stephens SH, Logel J, Barton A, Franks A, Schultz J, Short M, et al. (2009). Association of the 5-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophr Res 109:102-112.
95. Todtenkopf MS, Vincent SL, Benes FM (2005). A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain. Schizophr Res 73:79-89.
96. Tsuang DW, Skol AD, Faraone SV, Bingham S, Young KA, Prabhudesai S, et al. (2001). Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. Am J Med Genet 105:662-668.
97. Turecki G, Grof P, Grof E, D'Souza V, Lebuis L, Marineau C, et al. (2001). Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry 6:570-578.
98. Waldo M, Myles-Worsley M, Madison A, Byerley W, Freedman R (1995). Sensory gating deficits in parents of schizophrenics. Am J Med Genet 60:506-511.
99. Wang GS, Cooper TA (2007). Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8:749-761.
100. Xu J, Pato MT, Torre CD, Medeiros H, Carvalho C, Basile VS, et al. (2001). Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families. Am J Med Genet 105:669-674. (Pubitemid 33101465)
101. Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, et al. (2007). Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry 191:402-407.
102. Zhao L, Kuo YP, George AA, Peng JH, Purandare MS, Schroeder KM, et al. (2003). Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line. J Pharmacol Exp Ther 305:1132-1141.